New hope for tough lymphomas? early trial of NB02 begins
Disease control
Recruiting now
This early-phase trial is testing a new drug called NB02 (posseltinib) in 9 adults with certain types of Non-Hodgkin lymphoma (follicular, mantle cell, or marginal zone) that have returned or not responded to at least two prior treatments. The main goals are to find a safe dose a…
Phase: PHASE1 • Sponsor: NOBO Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC